155 related articles for article (PubMed ID: 37386468)
1. Significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with SHINE syndrome: a case report.
Yang M; Rubin A; Wondimu R; Grebe T; Ritfeld G
BMC Psychiatry; 2023 Jun; 23(1):483. PubMed ID: 37386468
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey.
Yalcin O; Kaymak G; Erdogan A; Tanidir C; Karacetin G; Kilicoglu AG; Mutlu C; Adaletli H; Gunes H; Bahali K; Ayik B; Uneri OS
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):815-821. PubMed ID: 26771824
[TBL] [Abstract][Full Text] [Related]
3. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
[TBL] [Abstract][Full Text] [Related]
4. Clozapine use in early psychosis.
Thien K; Bowtell M; Eaton S; Bardell-Williams M; Downey L; Ratheesh A; McGorry P; O'Donoghue B
Schizophr Res; 2018 Sep; 199():374-379. PubMed ID: 29525463
[TBL] [Abstract][Full Text] [Related]
5. Early use of clozapine for poorly responding first-episode psychosis.
Agid O; Remington G; Kapur S; Arenovich T; Zipursky RB
J Clin Psychopharmacol; 2007 Aug; 27(4):369-73. PubMed ID: 17632221
[TBL] [Abstract][Full Text] [Related]
6. Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder.
Wagstaff A; Perry C
CNS Drugs; 2003; 17(4):273-80; discussion 281-3. PubMed ID: 12665398
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
[TBL] [Abstract][Full Text] [Related]
8. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment.
Kaneda Y; Jayathilak K; Meltzer H
Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677
[TBL] [Abstract][Full Text] [Related]
9. Clozapine as treatment of first choice in first psychotic episodes. What do we know?
Vera I; Rezende L; Molina V; Sanz-Fuentenebro J
Actas Esp Psiquiatr; 2012; 40(5):281-9. PubMed ID: 23076611
[TBL] [Abstract][Full Text] [Related]
10. Dopamine supersensitivity psychosis and delay of clozapine treatment in patients with treatment-resistant schizophrenia.
Masumo Y; Kanahara N; Kogure M; Yamasaki F; Nakata Y; Iyo M
Int Clin Psychopharmacol; 2023 Mar; 38(2):102-109. PubMed ID: 36719338
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
[TBL] [Abstract][Full Text] [Related]
12. Investigating Predictors of Clozapine Response in Adolescents with Schizophrenia and Schizoaffective Disorder.
Karacetin G; Ermis C; Bulanik Koc E; Saglam Y
J Child Adolesc Psychopharmacol; 2021 Sep; 31(7):504-510. PubMed ID: 34283936
[No Abstract] [Full Text] [Related]
13. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
[TBL] [Abstract][Full Text] [Related]
14. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders.
de Haan L; Linszen DH; Gorsira R
J Clin Psychiatry; 1999 Jun; 60(6):364-5. PubMed ID: 10401913
[TBL] [Abstract][Full Text] [Related]
15. A Retrospective Multicenter Evaluation of Clozapine Use in Pediatric Patients Admitted for Acute Psychiatric Hospitalization.
Steinauer LM; Leung JG; Burkey BW; McGrane IR; Letts V; Goren JL; Hoeft DM; Mullen S; Maroney M; Schak KM; Vande Voort JL
J Child Adolesc Psychopharmacol; 2018 Nov; 28(9):615-619. PubMed ID: 30358422
[TBL] [Abstract][Full Text] [Related]
16. Treatment resistant schizophrenia - review and a call to action.
Lally J; Gaughran F
Ir J Psychol Med; 2019 Dec; 36(4):279-291. PubMed ID: 30477599
[TBL] [Abstract][Full Text] [Related]
17. Clozapine Associated Periorbital Edema in First Episode Psychosis: A Case Report of a Rare Adverse Effect in Treatment-Resistant Schizophrenia.
Teodoro T; Nogueira V; Aldeias J; Teles Martins M; Salgado J
J Clin Psychopharmacol; 2022 Nov-Dec 01; 42(6):594-596. PubMed ID: 36066404
[No Abstract] [Full Text] [Related]
18. CBTp for people with treatment refractory schizophrenia on clozapine: a systematic review and meta-analysis.
Todorovic A; Lal S; Dark F; De Monte V; Kisely S; Siskind D
J Ment Health; 2023 Feb; 32(1):321-328. PubMed ID: 33076721
[TBL] [Abstract][Full Text] [Related]
19. Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses.
Lally J; Ajnakina O; Di Forti M; Trotta A; Demjaha A; Kolliakou A; Mondelli V; Reis Marques T; Pariante C; Dazzan P; Shergil SS; Howes OD; David AS; MacCabe JH; Gaughran F; Murray RM
Psychol Med; 2016 Nov; 46(15):3231-3240. PubMed ID: 27605254
[TBL] [Abstract][Full Text] [Related]
20. Use of clozapine in a child with treatment-resistant schizophrenia.
MacEwan TH; Morton MJ
Br J Psychiatry; 1996 Mar; 168(3):376-8. PubMed ID: 8833696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
